MDAI
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Graham Number and Intrinsic Value are unavailable due to negative earnings and equity.
- Negative Price/Book ratio
- P/S of 3.00 is expensive for a company with shrinking revenue
Growth metrics are trending sharply downward.
- Analyst optimism
- Revenue growth is -46.30% YoY
- Q/Q revenue growth is -46.27%
Long-term performance is overwhelmingly negative.
- 1Y price return of +48%
- 5Y change of -81.1%
- Consistent history of earnings misses
The company fails every deterministic health check.
- Piotroski F-Score 0/9
- Current Ratio < 1.0
- Negative ROA
Dividend strength is 0/100.
- No dividend paid
- No capacity for dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for MDAI and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
MDAI
Spectral AI, Inc.
Primary
|
-81.1% | -87.0% | +48.0% | -16.3% | +40.1% | +11.4% |
|
LUNG
Pulmonx Corporation
Peer
|
-96.7% | -86.8% | -73.4% | -9.4% | -14.3% | +5.9% |
|
DCGO
DocGo Inc.
Peer
|
-94.3% | -93.1% | -77.6% | -55.1% | -15.2% | -9.4% |
|
BTMD
biote Corp.
Peer
|
-85.2% | -74.7% | -54.1% | -47.5% | -16.8% | +10.4% |
|
ICCC
ImmuCell Corporation
Peer
|
-21.2% | +44.8% | +39.6% | +4.1% | +6.5% | +9.9% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
MDAI
Spectral AI, Inc.
|
BEARISH | $58.87M | - | -% | -38.5% | $1.85 | |
|
LUNG
Pulmonx Corporation
|
BEARISH | $60.82M | - | -77.2% | -59.7% | $1.44 | Compare |
|
DCGO
DocGo Inc.
|
BEARISH | $56.28M | - | -89.0% | -56.6% | $0.57 | Compare |
|
BTMD
biote Corp.
|
NEUTRAL | $55.53M | 2.01 | -% | 14.1% | $1.49 | Compare |
|
ICCC
ImmuCell Corporation
|
BEARISH | $64.01M | - | -3.8% | -3.8% | $7.08 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-27 | CAPONE VINCENT S | Chief Executive Officer | Stock Award | 16,750 | $25,460 |
| 2026-03-27 | DIMAIO JOHN MICHAEL | Director | Stock Award | 7,619 | $12,038 |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning MDAI from our newsroom.